A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.

PubWeight™: 7.72‹?› | Rank: Top 0.1%

🔗 View Article (PMID 9098027)

Published in Gastroenterology on April 01, 1997

Authors

A Lee1, J O'Rourke, M C De Ungria, B Robertson, G Daskalopoulos, M F Dixon

Author Affiliations

1: School of Microbiology and Immunology, The University of New South Wales, Sydney, Australia.

Articles citing this

(truncated to the top 100)

Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72

A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A (2000) 6.85

Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun (2000) 3.13

Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70

Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A (2001) 2.43

The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci U S A (2004) 2.32

Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun (2001) 2.30

Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun (2002) 2.24

Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology (2010) 2.17

Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14

The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun (1998) 2.05

Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infect Immun (2003) 2.02

Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun (2001) 1.94

Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization. J Bacteriol (2001) 1.85

Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog (2013) 1.84

Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect Immun (2005) 1.75

Helicobacter pylori possesses two CheY response regulators and a histidine kinase sensor, CheA, which are essential for chemotaxis and colonization of the gastric mucosa. Infect Immun (2000) 1.75

Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol (1999) 1.74

Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun (2004) 1.72

Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol (2004) 1.72

Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun (1999) 1.69

Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2000) 1.67

Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol (1999) 1.65

Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect Immun (1998) 1.64

Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun (1998) 1.61

Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun (2003) 1.60

Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun (1998) 1.60

Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect Immun (2006) 1.59

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother (2000) 1.58

comH, a novel gene essential for natural transformation of Helicobacter pylori. J Bacteriol (2000) 1.57

Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun (1997) 1.57

Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect Immun (1999) 1.56

The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol (2006) 1.55

Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54

Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun (1999) 1.49

Maintenance of Helicobacter pylori cultures in agar stabs. Helicobacter (2010) 1.46

gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect Immun (2001) 1.44

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J (2004) 1.42

Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility. J Bacteriol (1999) 1.40

Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun (1998) 1.40

Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun (2007) 1.39

Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J Bacteriol (2001) 1.39

Switching of flagellar motility in Helicobacter pylori by reversible length variation of a short homopolymeric sequence repeat in fliP, a gene encoding a basal body protein. Infect Immun (2000) 1.39

Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci (2004) 1.37

Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect Immun (2002) 1.37

Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice. Am J Pathol (2007) 1.35

Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35

Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun (1997) 1.34

Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun (2001) 1.33

Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun (2005) 1.32

Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun (2007) 1.31

Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun (1999) 1.26

Gastric Sonic Hedgehog acts as a macrophage chemoattractant during the immune response to Helicobacter pylori. Gastroenterology (2012) 1.26

Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice. Am J Pathol (1998) 1.24

Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer (2010) 1.22

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol (2004) 1.22

ChePep controls Helicobacter pylori Infection of the gastric glands and chemotaxis in the Epsilonproteobacteria. MBio (2011) 1.22

16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.21

In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun (2002) 1.21

Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori. Appl Environ Microbiol (2008) 1.21

Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun (1999) 1.21

Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun (2004) 1.21

Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun (2009) 1.20

The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes (2013) 1.20

Contraselectable streptomycin susceptibility determinant for genetic manipulation and analysis of Helicobacter pylori. Appl Environ Microbiol (2006) 1.20

Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun (2003) 1.19

Expanding the Helicobacter pylori genetic toolbox: modification of an endogenous plasmid for use as a transcriptional reporter and complementation vector. Appl Environ Microbiol (2007) 1.18

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother (2006) 1.18

Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Infect Immun (2003) 1.17

Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2001) 1.17

Two predicted chemoreceptors of Helicobacter pylori promote stomach infection. Infect Immun (2002) 1.16

Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A (2003) 1.16

Presence of active aliphatic amidases in Helicobacter species able to colonize the stomach. Infect Immun (2003) 1.15

Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun (2003) 1.15

Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun (2000) 1.15

Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun (2007) 1.15

Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother (1999) 1.14

Motility of urease-deficient derivatives of Helicobacter pylori. J Bacteriol (2004) 1.14

Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol (2011) 1.14

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut (2001) 1.13

Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect Immun (2002) 1.12

Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun (1998) 1.12

Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine (2009) 1.11

Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect Immun (2003) 1.11

Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10

Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol (2010) 1.10

A conventional beagle dog model for acute and chronic infection with Helicobacter pylori. Infect Immun (1999) 1.09

Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res (2008) 1.09

CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun (2006) 1.08

Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun (2005) 1.08

Roles of alpha and beta carbonic anhydrases of Helicobacter pylori in the urease-dependent response to acidity and in colonization of the murine gastric mucosa. Infect Immun (2007) 1.08

A fixed-time diffusion analysis method determines that the three cheV genes of Helicobacter pylori differentially affect motility. Microbiology (2009) 1.08

In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07

Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model. Antimicrob Agents Chemother (2003) 1.07

Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.07

Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection. Infect Immun (2002) 1.07

Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice. Proc Natl Acad Sci U S A (2002) 1.07

Mouse models of gastric cancer. Cancers (Basel) (2013) 1.07

Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol (2006) 1.06

Articles by these authors

(truncated to the top 100)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13

Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry (1991) 4.43

Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24

A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc (1997) 4.09

Driven DNA transport into an asymmetric nanometer-scale pore. Phys Rev Lett (2000) 4.06

Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77

Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66

Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23

Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21

Treponema pallidum haemagglutination test for syphilis. Comparison with TPI and FTA-ABS tests. Br J Vener Dis (1972) 3.19

Isolation of a spiral-shaped bacterium from the cat stomach. Infect Immun (1988) 2.98

Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98

Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73

Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J Clin Microbiol (1996) 2.72

Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60

Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59

Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58

Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53

An uncultured gastric spiral organism is a newly identified Helicobacter in humans. J Infect Dis (1993) 2.53

Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut (1991) 2.35

Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31

Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31

Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27

Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr (1993) 2.25

Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21

An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21

Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17

Simultaneous multianalyte detection with a nanometer-scale pore. Anal Chem (2001) 2.17

Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis (1996) 2.17

The natural course of gallstone disease: eleven-year review of 781 nonoperated cases. Gastroenterology (1966) 2.11

Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. N Engl J Med (1994) 2.09

Blindness after reduction of facial fractures. Plast Reconstr Surg (1998) 2.08

Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut (1989) 2.06

Pulmonary epithelial permeability. An animal study of inverse ratio ventilation and conventional mechanical ventilation. Chest (1996) 2.02

A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proc Natl Acad Sci U S A (2000) 2.01

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics (1999) 2.01

Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00

PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00

Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99

Treponema pallidum haemagglutination test for yaws. Comparison with the TPI and FTA-ABS tests. Br J Vener Dis (1972) 1.98

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94

Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93

Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92

Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92

Fibrinolytic activity of human veins. Lancet (1967) 1.91

In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand (1980) 1.86

Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82

Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut (1996) 1.82

The impact of nausea and vomiting upon quality of life measures. Br J Cancer Suppl (1992) 1.81

Interacting proteins identified by genetic interactions: a missense mutation in alpha-tubulin fails to complement alleles of the testis-specific beta-tubulin gene of Drosophila melanogaster. Mol Cell Biol (1989) 1.80

Inhibitory post-synaptic currents in rat hippocampal CA1 neurones. J Physiol (1984) 1.79

Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome. Arch Dis Child (1988) 1.76

The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72

Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71

Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics (1992) 1.71

Blood Transfusion in Severe Burns in Infants and Young Children: A Preliminary Report of the Treatment of the Toxic Shock by Blood Transfusion-with or without preceding exsanguination. Can Med Assoc J (1921) 1.71

p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70

MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70

Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70

The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev (1988) 1.69

Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68

The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68

Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem (1987) 1.67

Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66

Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64

Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62

c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61

Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61

Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60

Measurement of quality of life in patients with cancer. Cancer Surv (1987) 1.60

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest (1994) 1.60

Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60

Corticosteroid therapy for the pregnant asthmatic patient. JAMA (1975) 1.59

Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58

Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58

Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57

High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56

Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54

Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52

Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51

Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50

Patch-clamp recordings from cerebellar basket cell bodies and their presynaptic terminals reveal an asymmetric distribution of voltage-gated potassium channels. J Neurosci (1998) 1.50

Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48

Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology (1999) 1.47

The appendix as a 'skip lesion' in ulcerative colitis. Histopathology (1990) 1.46

Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A (1990) 1.45

Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer (1997) 1.45

Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45

Hyperpolarization-activated currents in presynaptic terminals of mouse cerebellar basket cells. J Physiol (2000) 1.45

Molecular analysis of urease genes from a newly identified uncultured species of Helicobacter. Infect Immun (1994) 1.44

Anaplastic gastric adenocarcinoma with extensive neutrophilic infiltration. Histopathology (1998) 1.44